POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (6.12.2021, 3:33pm CEST, WHO):   U.S. 13,304    India 84,332    Brazil 88,092    France 3,639    Turkey 6,261    Russia 13,510    The United Kingdom 7,958    Italy 1,892    Argentina 27,628    Germany 1,911    Columbia 29,302    Iran 9,966    Mexico 3,672    Ukraine 1,274    Peru 4,054    Indonesia 8,083    South Africa 8,020    The Netherlands 1,417    Chile 7,941    Canada 1,476    Philippines 6,686    Iraq 4,320    Pakistan 1,303    Bangladesh 2,454    Japan 1,920    Malaysia 6,849    Nepal 2,709    United Arab Emirates 2,281    Saudi Arabia 1,175    Ecuador 1,098    Belarus 1,026    Bolivia 3,233    Paraguay 2,758    Tunisia 2,161    Costa Rica 2,041    Uruguay 3,622    Kuwait 1,657    Dominican Republic 1,129    Guatemala 1,861    Venezuela 1,083    Sri Lanka 2,789    Thailand 3,277    Cuba 1,288    Zambia 2,065    Afghanistan 1,024    Mongolia 1,622    Namibia 1,432    Botswana 1,392    Uganda 1,566    China 322    Singapore 9    New Zealand 0    Australia 3    South Korea 565   

U.S. approves first self-administered coronavirus test

Christian Fernsby |
The U.S. Food and Drug Administration (FDA) said on Tuesday that it had authorized the country's first coronavirus diagnostic kit for self-testing at home.

Article continues below




Users can collect a sample with nasal swabs included in the all-in-one test kit and swirl the swab in a vial. In at most 30 minutes, the results whether a person is positive or negative for the novel coronavirus can be read from the test unit's light-up display, the FDA said in a statement.

The test kit, made by Lucira Health, has been authorized for home use for individuals aged 14 and older who are suspected of coronavirus by their health care provider.

The test can also be used in point-of-care (POC) settings emergency rooms or hospitals for example for all ages, but samples of those younger than 14 must be collected by a healthcare provider, the FDA said.

"While coronavirus diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home," FDA Commissioner Stephen M. Hahn said.

The single-use test is currently authorized for prescription use only.


What to read next

More self-help books, more depression
Instant HIV home test launched in the Netherlands
Artery tests appear to function differently for women and men